CI:NYE-Cigna Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 315.99

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.67M

Analyst Target

USD 242.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 268.12B
ELV Elevance Health Inc

N/A

USD 84.11B
CNC Centene Corp

N/A

USD 28.07B
MOH Molina Healthcare Inc

N/A

USD 17.62B
OSCR Oscar Health Inc

N/A

USD 4.46B
NEUE NeueHealth Inc

N/A

USD 0.06B
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CI

PINK Simplify Exchange Traded .. 4.57 % 0.00 %

N/A

USD 0.13B
AILV 4.45 % 0.00 %

N/A

N/A
MFSV MFS Active Value ETF 3.32 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
BUSA 2023 EFT Series Trust - B.. 2.44 % 0.00 %

N/A

USD 0.23B
FHH:CA First Trust AlphaDEX US H.. 2.32 % 0.77 %

N/A

CAD 0.01B
FDWM Fidelity Covington Trust .. 1.90 % 0.00 %

N/A

USD 3.94M
JAVA JPMorgan Active Value ETF 1.55 % 0.00 %

N/A

USD 3.38B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSE:F Invesco Quantitative Stra.. 1.53 % 0.00 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 1.48 % 0.00 %

N/A

CAD 0.01B
ZUH:CA BMO Equal Weight US Healt.. 1.48 % 0.39 %

N/A

CAD 0.21B
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.10B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.10B
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

N/A

USD 1.89B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

N/A
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 9.47M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.24B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.18B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
LONG:CA CI Global Longevity Econo.. 0.00 % 0.00 %

N/A

CAD 3.64M
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.08B
NTZG 0.00 % 0.00 %

N/A

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
IFSW:SW iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.60B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.43% 89% A- 89% A-
Dividend Return 0.55% 80% B- 23% F
Total Return 14.98% 89% A- 89% A-
Trailing 12 Months  
Capital Gain -5.00% 78% C+ 32% F
Dividend Return 1.72% 80% B- 35% F
Total Return -3.28% 78% C+ 29% F
Trailing 5 Years  
Capital Gain 67.19% 83% B 65% D
Dividend Return 10.85% 50% F 26% F
Total Return 78.04% 100% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 10.86% 78% C+ 73% C
Dividend Return 12.54% 89% A- 72% C
Total Return 1.68% 80% B- 40% F
Risk Return Profile  
Volatility (Standard Deviation) 22.46% 67% D+ 44% F
Risk Adjusted Return 55.82% 100% F 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:

There is nothing we particularly dislike